Exercise-Induced Increase in Serum Irisin Levels is Associated with Antioxidant Effects of Silymarin in Dexamethasone- Induced NAFLD Authors: Maedeh Ghasemi, Mohammad Reza Lotfi, Fatemeh Mokhtari-Andani, Fouzieh Zadhoush Published: 2025 ABSTRACT Background:Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with no specific treatment. We examined the effects of silymarin, exercise, and their combination on the serum levels of oxidant/antioxidant markers, as well as irisin—a myokine secreted by muscles during exercise—in dexamethasone-induced NAFLD in adult male rats.Methods:In this experimental animal study, forty-two male Wistar rats were randomly grouped into control (normal saline), NAFLD (dexamethasone injection at 10 mg/kg/day, s.c. for 7 days to induce NAFLD), NAFLD + exercise training (continuous exercise training 5 days/week for 8 weeks), NAFLD + silymarin (1 mg/kg/day, orally for 8 weeks), NAFLD + exercise training + silymarin, and NAFLD + pioglitazone (positive control, 1 mg/kg/day, orally for 8 weeks) groups (n = 7 for each). The serum levels of oxidant markers, malondialdehyde (MDA); antioxidant markers, superoxide dismutase (SOD); total antioxidant capacity (TAC); and irisin were determined using specific ELISA kits.Results:Oxidant markers, such as MDA, were significantly enhanced while antioxidant markers, such as SOD and TAC, as well as serum levels of irisin, were significantly diminished in rats with NAFLD compared to controls. Combining silymarin and 8-week continuous training exercise resulted in significant restoration of serum levels of MDA, TAC, and irisin to control values. While combined treatment had a significant impact on oxidant/antioxidant status in NAFLD rats, it was not more effective than either treatment alone. However, it was observed that the serum level of irisin increased more in combination therapy.Conclusions:Our findings suggest that combination treatment with silymarin and exercise may have a protective effect against NAFLD, partly by reducing oxidative stress and increasing serum levels of irisin. Introduction Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide and can progress to cirrhosis and hepatocellular carcinoma.[1] Approximately 25% of the global population is affected by NAFLD,[2] though the true prevalence may be much higher due to changes in dietary habits and the increasing trend towards sedentary lifestyles.[3] Physical activity, especially structured exercise, is currently considered one of the most effective treatments for NAFLD.[4] Exercise has been shown to positively impact many aspects of NAFLD, including its early stages, associated cardiovascular diseases, hepatocellular carcinoma, and weight reduction.[5] However, more research is needed to determine the most beneficial type and duration of exercise training and to understand the precise mechanisms underlying improvements in NAFLD. Oxidative stress plays a significant role in the development of NAFLD.[6] It is defined as the excessive generation of free radicals and reactive oxygen species (ROS), which can occur due to an imbalance in the antioxidant system—either through increased pro-oxidant production, reduced antioxidant activity, or both.[7] Exercise has been shown to protect against oxidative stress in both animal and human studies. Clinical studies have demonstrated that both long-term[8910] and short-term[11] exercise programs can reduce ROS production and lipid peroxidation in NAFLD patients. Additionally, multiple myokines, including irisin, are released from muscles during exercise and constitute an important component of lifestyle modifications in the treatment of NAFLD.[5] Irisin is an exercise-induced myokine released by skeletal muscle in both humans and rodents,[1213] entering the bloodstream during physical activity[14] and playing a significant role in energy homeostasis.[12] It has been shown to improve liver lipid accumulation,[1516] insulin resistance,[1217] and metabolic processes.[18] Recent studies have found that irisin levels are associated with NAFLD. Some evidence suggests lower irisin levels in obese individuals and NAFLD patients compared to healthy controls. Moreover, irisin levels were found to be negatively correlated with NAFLD-related indices, indicating its potential as a diagnostic marker for NAFLD, warranting further investigation. The relationship between irisin and oxidative stress in metabolic diseases has been suggested by multiple studies, indicating a potential role for irisin as a metabolic protective hormone.[19] Furthermore, adding irisin to murine macrophages in vitro protects against oxidative stress by enhancing the expression of antioxidative enzymes.[20] However, there have been controversial findings regarding the role of irisin in oxidative stress induced by NAFLD.[2122] A recent study, however, provides novel evidence that exercise-induced irisin improves NAFLD by inhibiting inflammation. In recent years, combination therapy has emerged as a powerful approach to combat various diseases. Numerous studies have shown that herbal medicines combined with exercise can be more effective than either treatment alone. Silymarin, a flavonolignan extracted from Milk Thistle seeds, has antioxidant and anti-inflammatory effects.[2324252627] It remains unknown whether the combination of silymarin and exercise would have greater protective effects against NAFLD than either treatment alone through altering systemic irisin levels. Therefore, we assessed the effects of the combination of silymarin and exercise on the enzymatic antioxidant superoxide dismutase (SOD), total antioxidant capacity (TAC), the lipid peroxidation end product malondialdehyde (MDA), and serum irisin levels in adult male rats with NAFLD. Material and Methods Chemicals The TAC, SOD, and MDA assay kits were obtained from Kiazist Co. (Iran). Silymarin (Silybinin) was acquired from Barich Essence Co. (Kashan, Iran). The irisin enzyme-linked immunosorbent assay (ELISA) kit was supplied by Zellbio Co. (Germany). Dexamethasone was sourced from Darou Pakhsh Pharma Chem Co. (Iran), and pioglitazone was supplied by Tehran Chemie Pharmaceutical Co. (Iran). Animals Male Wistar rats (220 g–230 g) were obtained from the Pasteur Institute in Iran. The rats were housed in groups of four under standard laboratory conditions, in clear polycarbonate cages, and maintained on a 12:12-hour light-dark cycle at 22°C ± 1°C and 55% humidity. They were provided with ad libitum access to food (laboratory pellets or lab blocks for the basic diet) and water. The animals were acclimatized for one week before the experiment. To induce NAFLD, dexamethasone (10 mg/kg) was administered subcutaneously (s.c.) to the rats for 7 days.[28] Rats were weighed weekly to monitor changes in body weight. All experimental protocols were approved by the Animal Research Ethics Committee of Isfahan University of Medical Sciences and were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (ethical approval code: IR.MUI.RESEARCH.REC.1401.088). After a one-week adaptation period, the animals were divided into six weight-matched groups (n = 7): 1) control, 2) dexamethasone (DEX), 3) DEX + pioglitazone, 4) DEX + silymarin, 5) DEX + exercise training, 6) DEX + silymarin + exercise training. To ethically use animals during the project, we emphasized the importance of refining to reduce or eliminate the discomfort of the rats. Our key strategies included reducing environmental stress and management, enriching environments and modifying exercise training methods, minimizing aversive stimuli, using anesthesia and analgesia at the end of the study, and implementing human endpoints if high-intensity injuries were observed. In the evaluation of pain, several behavioral parameters were considered in response to non-invasive stimuli such as animal handling. We monitored the general physical condition, body weight, and activity levels of the rats to ensure they were fit for the exercise protocol. Only rats that showed no signs of physical distress or illness were included in the study. Preparation of silymarin extract To prepare the aqueous silymarin extract, 5 g of silymarin powder was added to 100 ml of boiling distilled water and boiled for 20 min. The mixture was then cooled and filtered through Whatman filter paper (No. 1). The resulting silymarin solution was administered orally to the animals by gavage at a dose of 1 mg/kg/day for 8 weeks.[29] Exercise protocol In this experimental animal study, the rats in the exercise groups underwent continuous exercise training on a treadmill (5 times/week) for 8 weeks, following a modified exercise protocol from a previous study.[30] After 1 week of familiarization, the rats were placed on the treadmill for a 5 min warm-up at a speed of 10 m/min with a 0° incline. The rats then ran on the treadmill at a starting speed of 12 m/min and a 5% incline for a 12 min period in the first week, which was gradually increased until a speed of 20 m/min, a 15% incline, and a 54 min duration was reached in the final week. Light electric shocks (75 V, 0.2 mA, 50 Hz) were used to encourage the rats to run. Experimental design After 1 week of acclimatization, 42 male Wistar rats were randomly assigned to six groups (n = 7 for each) as follows: 1) Control group: Rats were injected with normal saline (1 mL/kg/day, s.c.)2) NAFLD group: Rats were injected with dexamethasone (10 mg/kg/day, s.c.) for 7 days to induce NAFLD3) NAFLD + exercise group: rats were injected with dexamethasone and subsequently subjected to continuous exercise training 5 days/week for 8 weeks[30]4) NAFLD + silymarin group: Rats were injected with dexamethasone and subsequently treated with silymarin (1 mg/kg/day, orally) for 8 weeks[29]5) NAFLD + exercise + silymarin group: Rats were injected with dexamethasone and subsequently treated with silymarin (1 mg/kg/day, orally) and continuous exercise training 5 days/week for 8 weeks6) NAFLD + pioglitazone (positive control group): Rats were injected with dexamethasone and subsequently treated with pioglitazone (1 mg/kg/day, orally).[31] 1) Control group: Rats were injected with normal saline (1 mL/kg/day, s.c.) 1) Control group: Rats were injected with normal saline (1 mL/kg/day, s.c.) 2) NAFLD group: Rats were injected with dexamethasone (10 mg/kg/day, s.c.) for 7 days to induce NAFLD 2) NAFLD group: Rats were injected with dexamethasone (10 mg/kg/day, s.c.) for 7 days to induce NAFLD 3) NAFLD + exercise group: rats were injected with dexamethasone and subsequently subjected to continuous exercise training 5 days/week for 8 weeks[30] 3) NAFLD + exercise group: rats were injected with dexamethasone and subsequently subjected to continuous exercise training 5 days/week for 8 weeks[30] 4) NAFLD + silymarin group: Rats were injected with dexamethasone and subsequently treated with silymarin (1 mg/kg/day, orally) for 8 weeks[29] 4) NAFLD + silymarin group: Rats were injected with dexamethasone and subsequently treated with silymarin (1 mg/kg/day, orally) for 8 weeks[29] 5) NAFLD + exercise + silymarin group: Rats were injected with dexamethasone and subsequently treated with silymarin (1 mg/kg/day, orally) and continuous exercise training 5 days/week for 8 weeks 5) NAFLD + exercise + silymarin group: Rats were injected with dexamethasone and subsequently treated with silymarin (1 mg/kg/day, orally) and continuous exercise training 5 days/week for 8 weeks 6) NAFLD + pioglitazone (positive control group): Rats were injected with dexamethasone and subsequently treated with pioglitazone (1 mg/kg/day, orally).[31] 6) NAFLD + pioglitazone (positive control group): Rats were injected with dexamethasone and subsequently treated with pioglitazone (1 mg/kg/day, orally).[31] Biochemical and histopathological analysis The rats were sacrificed 48 hours after the final training session. Blood samples were collected from the hearts of overnight (8 hours) fasted rats following an intraperitoneal injection of a ketamine (100 mg/kg) and xylazine (10 mg/kg) combination.[30] The blood samples were centrifuged at 3,000 rpm for 10 min, and the serum was then separated and stored at −80°C for subsequent biochemical analysis. For tissue fixation, liver tissues were collected immediately after euthanasia and fixed in 10% formalin at room temperature for 24 hours, followed by paraffin embedding for histopathological analysis. The tissue sections were stained with hematoxylin and eosin for histopathological assessment. Serum irisin levels were determined using an ELISA according to the manufacturer’s instructions. To measure oxidative stress, serum MDA, a reliable indicator of lipid peroxidation, was determined using an ELISA kit. The basis of the assay involved a reaction between MDA and thiobarbituric acid (TBA), resulting in the formation of a pink chromogen (TBARS), which was measured at 535 nm using the ELISA reader device. To measure antioxidant status, TAC and SOD serum levels were assessed. TAC was determined using an ELISA kit through a redox-based colorimetric method. SOD, an important antioxidant enzyme, was measured using an ELISA kit. The assessment of serum SOD was conducted with the SOD assay kit, based on the generation of superoxide ions and the reaction with tetrazolium, resulting in the formation of a formazan color that absorbs at 450 nm. Assessment of accuracy and precision in ELISA assays To assess the precision of the ELISA method, intra- and inter-assay variations were calculated using three replicates of each sample. The coefficient of variation (CV%) was determined, and values below 5% were considered acceptable. Accuracy was evaluated by calculating the recovery rate of spiked samples with known concentrations, with recovery rates between 80%–120% deemed acceptable. Standard controls provided by the ELISA kit manufacturer were included in each run for quality assurance. Statistical analysis All data were analyzed using Prism software (version 9). The results are reported as mean ± standard error of the mean (SEM). Normality of the data was tested using the Kolmogorov-Smirnov test, and homogeneity of variances was assessed using Levene’s test. Outliers were identified and excluded from the data analysis based on the criterion of being beyond ± 3 standard deviations (SD) from the mean. The mean values between the groups were compared using a one-way analysis of variance (ANOVA), followed by a post hoc Tukey test. A P value of less than 0.05 was considered significant. Results Effect of exercise and silymarin, alone and in combination, on serum irisin levels in NAFLD rats As shown in Figure 1, serum irisin levels were markedly reduced in the NAFLD group (3.381 ± 0.187 ng/ml) compared to the control group (5.674 ± 0.143 ng/m) (P < 0.05). In contrast, serum irisin levels were significantly increased in the NAFLD + exercise (8.148 ± 1.415 ng/ml, P < 0.01) and NAFLD + exercise + silymarin (9.144 ± 0.861 ng/ml, P < 0.001) groups compared to the NAFLD group. Irisin levels were also increased in the NAFLD + exercise + silymarin group compared to the control and NAFLD + pioglitazone groups (P < 0.05). Statistical analysis did not confirm a significant difference between the NAFLD group receiving silymarin and the combined treatment of silymarin + exercise, although an increase in irisin levels is visible in the NFLD + exercise + silymarin group (P = 0.053). Effect of exercise and silymarin alone and in combination on serum irisin levels in dexamethasone-induced NAFLD in rats. Irisin serum levels were significantly declined in the rats with NAFLD, while continuous exercise training alone and in combination with silymarin markedly restored serum irisin to control values. Values are shown as mean ± SEM. *P < 0.05 indicates a significant difference from the control group. $$P < 0.01 indicates a significant difference from the NAFLD group. #P < 0.05 indicates a significant difference from the pioglitazone group (positive control) Effect of exercise and silymarin, alone and in combination, on serum MDA levels in NAFLD rats As shown in Figure 2, the serum level of MDA was significantly increased in the NAFLD group (560 ± 89.65 nmol/ml) compared to the control group (66.62 ± 22.99 nmol/ml) (P < 0.001). Treatment with exercise and silymarin, alone and in combination, significantly reduced the serum MDA levels in the NAFLD + silymarin (44.37 ± 18.57 nmol/ml), NAFLD + exercise (55.08 ± 13.81 nmol/ml), and NAFLD + exercise + silymarin (56.08 ± 7.682 nmol/ml) groups when compared with that in the NAFLD group (P < 0.001). There was no noteworthy difference between the different NAFLD groups which treated with silymarin, silymarin + exercise, and pioglitazone (P > 0.05). Effect of exercise and silymarin alone and in combination on MDA levels in the serum in dexamethasone-induced NAFLD in rats. MDA levels were markedly enhanced in the NAFLD group, while treatment with silymarin and exercise alone and in combination reduced this effect. Values are shown as mean ± SEM. ***P < 0.001 indicates a significant difference from the control group. $$$P < 0.001 indicates a significant difference from the NAFLD group Effect of exercise and silymarin, alone and in combination, on serum TAC levels in NAFLD rats In this study, the serum level of TAC, an indicator of various potential antioxidants, was measured in different groups. Results in Figure 3 showed a significant reduction in the serum level of TAC in the NAFLD group (8.298 ± 1.277 nmol/ml) compared to the control group (17.5 ± 2.025 nmol/ml) (P < 0.05). Treatment with silymarin significantly increased the TAC serum level in the NAFLD + silymarin group (18.7 ± 1.302 nmol/ml) relative to the NAFLD group (P < 0.05). TAC levels were also elevated in the NAFLD + exercise (15.84 ± 2.726 nmol/ml) and NAFLD + exercise + silymarin (12.0 ± 0.924 nmol/ml) groups compared to the NAFLD group, although this effect was not significant (P > 0.05). Effect of exercise and silymarin alone and in combination on TAC levels in the serum in dexamethasone-induced NAFLD in rats. TAC levels were notably reduced in the NAFLD group, while treatment with silymarin markedly restored serum MDA to control levels. Values are shown as mean ± SEM. *P < 0.05 indicates a significant difference from the control group. $P < 0.05 indicates a significant difference from the NAFLD group Effect of exercise and silymarin, alone and in combination, on the serum SOD levels of in NAFLD rats In this study, we also measured the serum levels of SOD, as an individual indicator of antioxidant status, in various groups. Results in Figure 4 indicated that the serum level of SOD was markedly lower in the NAFLD group (8.716 ± 1.536 nmol/ml) than in the control group (27.95 ± 3.187 nmol/ml) (P < 0.001). Treatment with silymarin significantly increased the SOD level in the NAFLD + silymarin group (21.89 ± 3.423 nmol/ml, P < 0.05) compared to the NAFLD group. The serum level of SOD was also increased in the NAFLD + exercise + silymarin group (16.04 ± 2.985 nmol/ml) compared with the NAFLD group, although this increase was not significant (P > 0.05). There was no significant difference between the different groups of NAFLD treated with silymarin, silymarin + exercise, and pioglitazone (P > 0.05). Effect of exercise and silymarin alone and in combination on the serum levels of SOD in dexamethasone-induced NAFLD in rats. SOD serum levels were significantly declined in the NAFLD group, while treatment with silymarin alone enhanced the SOD level compared to the NAFLD group. Values are shown as mean ± SEM. *P < 0.05 and ***P < 0.001 indicate a significant difference from the control group. $P < 0.05 indicates a significant difference from the NAFLD group Effect of exercise and silymarin, alone and in combination, on histopathological findings in NAFLD rats As shown in Figure 5, liver tissue analysis in the control group revealed normal structural integrity, with hepatocytes maintaining their architecture, free from inflammatory damage or fat accumulation. In contrast, the NAFLD group exhibited significant cellular disruption, including marked hepatocyte damage, nuclear abnormalities, and infiltration of inflammatory cells. Histopathological examination of Rat liver (H and E staining, magnification 40X and 200X). Liver sections from the control group displayed normal hepatic morphology with intact cellular structure. In contrast, liver sections from NAFLD-induced rats exhibited marked pathological changes, including enhanced cellular lesions, structural disarrangement, accumulation of inflammatory cells, and fat deposits (highlighted by red arrows). However, liver sections from all treatment groups showed minimal degeneration and largely preserved hepatic architecture, indicating a protective effect of the interventions In the NAFLD groups treated with exercise and silymarin, a notable reduction in liver tissue damage was observed. This included decreased inflammatory cell infiltration, reduced cell lysis, and improved nuclear integrity, suggesting a protective and reparative effect of the treatments against tissue damage induced by dexamethasone. Discussion Currently, exercise is considered the cornerstone of treatment for NAFLD[4]; however, the precise mechanisms underlying its beneficial effects remain incompletely understood. Moreover, emerging evidence suggests that combining exercise with herbal medicine may enhance therapeutic outcomes compared to either intervention alone. Summary of findings In this study, we investigated the effects of silymarin, exercise, and their combination on serum irisin levels and oxidative/antioxidative markers in a rat model of dexamethasone-induced NAFLD. Both interventions showed beneficial effects, albeit through different mechanisms. Exercise demonstrated a greater impact on increasing irisin levels, while silymarin showed more pronounced improvements in certain oxidative stress markers. The combination of these approaches may provide the best outcomes due to their synergistic effects. Comparison with previous studies NAFLD is characterized by lipid accumulation in hepatocytes in the absence of significant alcohol consumption.[32] Hepatic lipid overload leads to excessive production of oxidants, resulting in oxidative damage to cellular macromolecules such as DNA, proteins, and lipids, ultimately causing liver injury.[33] Oxidative stress is widely recognized as a key driver of liver injury and the progression of NAFLD.[34] In this study, rats in the NAFLD group displayed elevated levels of the oxidative stress marker MDA and reduced levels of the antioxidant markers SOD and TAC compared to the control group. However, combined therapy with exercise and silymarin reduced serum MDA levels while increasing serum TAC and SOD levels in NAFLD rats compared to the controls. Nevertheless, the combined treatment did not show superior efficacy compared to either treatment (silymarin or exercise) alone. In comparison with previous studies, our findings are consistent with those demonstrating that exercise reduces ROS and enhances antioxidant levels in NAFLD patients. For instance, a 12-week exercise program significantly decreased serum ROS levels in middle-aged obese women with NAFLD.[8910] In another study, seven days of aerobic exercise significantly reduced ROS production during an oral glucose challenge in patients with NAFLD, which was accompanied by an improvement in hepatic lipid composition.[11] In rats, eight weeks of treadmill exercise led to a decrease in intrahepatic triglyceride levels and oxidative stress, as evidenced by a significant reduction in serum MDA levels, a marker of lipid peroxidation.[35] In addition to exercise, silymarin has also been shown to protect against oxidative stress.[27] For example, silymarin reduced hepatic steatosis, an early stage of NAFLD, in mice by modulating lipid metabolism and oxidative stress.[36] In another study, treatment of NAFLD mice with Silybum marianum oil attenuated liver cholesterol, free fatty acids, and triglyceride levels, increased SOD activity, and reduced MDA levels in the liver, which were associated with a decrease in histological liver injury.[37] Ebrahimpour Koujan et al. (2015)[38] also demonstrated that silymarin supplementation significantly enhanced antioxidant markers such as SOD and TAC, while reducing MDA levels in patients with type 2 diabetes mellitus compared to the placebo group. Together, these findings suggest that the protective effects of silymarin and exercise on NAFLD may be partly attributed to their ability to reduce oxidative stress. Another potential mechanism by which exercise may protect against NAFLD is through its effect on serum irisin levels. It is well-established that the myokine irisin is released from muscles into the bloodstream during physical exercise.[1213] However, studies examining the relationship between irisin levels and NAFLD have reported conflicting results. For instance, Kosmalski et al. (2022)[39] found an increase in serum irisin levels in NAFLD patients, while other studies have shown reduced serum irisin levels in NAFLD patients[40] and in obese adolescents, both with and without NAFLD.[41] These findings are consistent with our own results, which demonstrated a significant decrease in circulating irisin in rats with NAFLD. Importantly, treatment with exercise—either alone or in combination with silymarin—substantially restored irisin levels to control values. However, this effect was not observed in rats treated with silymarin alone, suggesting that irisin may play a role in mediating some of the therapeutic benefits of exercise in the treatment of NAFLD. Mechanisms The beneficial effects of exercise and silymarin may be attributed to their impact on oxidative stress and irisin levels. Although the exact mechanisms by which irisin protects against NAFLD remain unclear, several potential pathways have been proposed. For example, irisin has been shown to stimulate the browning of adipose tissue in mice,[12] and the enhancement of brown fat formation has been associated with protection against obesity.[42] Given that obesity is a primary risk factor for NAFLD,[43] the anti-obesity effects of irisin could be a key mechanism through which it protects against NAFLD. Furthermore, exercise-induced irisin has been demonstrated to improve insulin resistance,[44] a major pathogenic factor in NAFLD.[18] Thus, irisin may play a protective role in the development and progression of NAFLD. Limitations While the results of this study provide valuable insights, several limitations should be considered. First, the sample size of n = 7 was relatively small, which may limit the statistical power and generalizability of the findings. Second, the short duration of the study means that long-term effects were not assessed, and future studies with longer follow-up periods are necessary to confirm the durability of the effects. Additionally, while we focused on oxidative stress markers and irisin levels, other pathways may also play crucial roles in the beneficial effects observed. While our findings suggest that combination therapy with silymarin and exercise could have therapeutic potential for NAFLD, these results are preliminary and specific to the conditions of our study. Future studies Future studies should investigate the long-term effects of combination therapy with silymarin and exercise on NAFLD. Additionally, research should explore the molecular mechanisms underlying these effects, particularly focusing on how irisin interacts with oxidative stress pathways. Larger, randomized controlled trials in human subjects are also necessary to confirm the translational potential of these findings. In this study, we examined, for the first time, the combined effects of silymarin and 8 weeks of continuous exercise training on oxidant/antioxidant status and serum irisin levels in dexamethasone-induced NAFLD in rats. Our results demonstrate that combination therapy effectively attenuates oxidative stress and increases serum irisin levels in NAFLD rats. These findings suggest that exercise and silymarin may serve as complementary strategies for managing oxidative stress and improving metabolic health in patients with NAFLD. However, further studies in human models are needed to confirm these effects and establish clinical guidelines. While previous studies have shown that combination therapy may offer more promising results than single treatments for NAFLD,[45] our study did not find a significant difference between combination therapy and either silymarin or exercise alone. Further research is needed to better understand the effects of combined silymarin and exercise treatments on NAFLD. Abbreviations NAFLD: Nonalcoholic fatty liver disease SOD: Superoxide dismutase TAC: Total antioxidant capacity MDA: Malondialdehyde Conflicts of interest There are no conflicts of interest.